Sirolimus-Based Immunosuppression for Treatment of Cutaneous Warts in Kidney Transplant Recipients

Authors

  • Shahrzad Shahidi Isfahan Kidney Diseases Research Center, Isfahan University of Medical Sciences, Isfahan, Iran
  • Firouzeh Moeinzadeh Isfahan Kidney Diseases Research Center, Isfahan University of Medical Sciences, Isfahan, Iran
  • Morteza Mohammadi Isfahan Kidney Diseases Research Center, Isfahan University of Medical Sciences, Isfahan, Iran
  • Ali Gholamrezaei Poursina Hakim Research Institute, Isfahan, Iran

Abstract

Dermatological complications, especially skin infections, are very common following organ transplantation, and result in a lot of distress in the recipient. Herpes zoster, herpes simplex, and human papillomavirus infections are common infections in kidney transplant recipients, and therapeutic management is usually disappointing in immunosuppression state. We report here 2 cases of kidney transplant recipients who developed diffuse human papillomavirus-induced cutaneous warts with no response to conventional treatments. According to similar reports in organ transplant recipients, we modified the immunosuppressive regimen by converting to sirolimus, which led to a rapid relief from cutaneous warts in both patients. This evidence along with other case reports suggest that conversion to sirolimus may be considered as an effective strategy in cases of giant or multiple viral warts in kidney and perhaps other transplant recipients.

Author Biographies

  • Firouzeh Moeinzadeh, Isfahan Kidney Diseases Research Center, Isfahan University of Medical Sciences, Isfahan, Iran
    MD, Internal Medicine Resident
  • Morteza Mohammadi, Isfahan Kidney Diseases Research Center, Isfahan University of Medical Sciences, Isfahan, Iran
    MD

Downloads

Published

2011-08-29

Issue

Section

CASE REPORT | Transplantation